Hillsdale Investment Management Inc. Glaukos Corp Transaction History

Hillsdale Investment Management Inc.

  • $1.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$58.58 - $83.91 $661,954 - $948,183
-11,300 Closed
0 $0
Q2 2019

Aug 02, 2019
BUY
$63.59 - $78.71 $718,567 - $889,422
11,300 New
11,300 $852,000
Q4 2018

Feb 12, 2019
SELL
$52.18 - $67.93 $62,616 - $81,516
-1,200 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$38.13 - $68.37 $45,756 - $82,044
1,200 New
1,200 $78,000

Others Institutions Holding GKOS

# of Institutions
340
Shares Held
47.1M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.73B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email